-
Study aim
-
Reducing the effects of septic shock with early treatment with hypertonic saline.
-
Design
-
Clinical trial with control group,with parallel groups,double-blind,randomized, phase 3 on 52 patients.For randomization based on a random sequence created from www.randomization.com and the order in which patients enter the study, they will be included in the control or intervention group.
-
Settings and conduct
-
Using random sampling and intensive care units, patients with severe sepsis are randomly divided (using closed envelopes) into two groups of control and intervention. Optical nerve diameter and hemodynamic parameters and gasometric parameters in the first and second hours The third treatment is recorded for comparison between the two groups.
The subjects and the treating physician will be unaware of the intervention and control groups (double-blind)
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:Patients with septic shock, age between 18-80 years
Exclusion criteria:Patient dissatisfaction,patients with incurable disseminated malignancy,patients with hyperthermia,patients receiving colloidal solutions and any volume limitation restrictions.
-
Intervention groups
-
In the intervention group, 5% hypertonic saline is prescribed at the beginning of septic shock treatment.
In the control group, conventional resuscitation (isotonic saline serum) is performed. In both groups, optic nerve diameter is measured by ultrasound before saline administration (without placebo).
-
Main outcome variables
-
Hemodynamic parameters (HR, SBP, DBP, MAP, CVP) and gasometric parameters (PH, PaCO2, PaO2, HCO3, BE, Lactate) and optic nerve diameter at the beginning of the study and in the first and second and third hours of intervention (optic nerve diameter At the beginning of the third hour of intervention), they are measured, recorded and compared.